Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CRL
EXEL
Add up to 3 more stocks
CRL
Charles River Laboratories International, Inc.
+7.09%
$310.77+20.58Delayed quote: Oct 5, 2026, 4:00 PM EDT
Market Cap
$14.97B
52W Range
$146.20 - $312.05
EXEL
Exelixis, Inc.
+0.79%
$58.85+0.46Delayed quote: Oct 5, 2026, 4:00 PM EDT
Market Cap
$14.79B
52W Range
$33.76 - $61.14
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 18.45 |
| Forward P/E | 27.39 | 16.75 |
| PEG Ratio | N/A | 0.36 |
| P/B Ratio | 5.27 | 8.02 |
| P/S Ratio | 3.74 | 6.07 |
| P/FCF Ratio | 40.39 | 12.77 |
| EV/EBITDA | 22.49 | 14.68 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 32.2% | 96.5% |
| Operating Margin | 12.3% | 39.9% |
| Net Margin | -6.0% | 35.3% |
| ROE | -8.4% | 46.7% |
| ROA | -3.2% | 34.5% |
| ROIC | 7.7% | 37.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.35 | 3.46 |
| Quick Ratio | 1.04 | 3.38 |
| Debt/Equity | 1.07 | 0.09 |
| Interest Coverage | 4.74 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.